Author:
Park Tristen S.,Phan Giao Q.,Yang James C.,Kammula Udai,Hughes Marybeth S.,Trebska-McGowan Kasia,Morton Kathleen E.,White Donald E.,Rosenberg Steven A.,Sherry Richard M.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. NCCN guideline insights: melanoma, version 3.2016. JNCCN, 2016.
2. Houghton A, et al. NCCN melanoma practice guidelines. Natl Compr Cancer Netw. Oncology (Williston Park), 1998;12(7A):153–77.
3. Balch CM, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635–48.
4. Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC, Topalian SL, Royal RE, Kammula U, Restifo NP, Hughes MS, Schwartzentruber D, Berman DM, Schwarz SL, Ngo LT, Mavroukakis SA, White DE, Steinberg SM. Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol. 2005;175(9):6169–76.
5. Rosenberg SA, Sherry RM, Morton KE, Yang JC, Topalian SL, Royal RE, Kammula US, Restifo NP, Hughes MS, Schwarz SL, Ngo LT, Mavroukakis SA, White DE. Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines. J Immunother. 2006;29(2):224–31.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献